This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Versitech, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Siu Tim Cheung and His Work on Liver Cancer Prognosis
Introduction
Siu Tim Cheung is an inventor associated with Hong Kong and research at The University of Hong Kong. His work includes an invention focused on prognosis and therapy for hepatocellular carcinoma, a common form of liver cancer. The available information lists 1 patent associated with him.
Latest Patents
Cheung’s listed patent, “Compositions and Methods for Prognosis and Therapy of Liver Cancer,” describes a composition containing polynucleotide probes, including probes associated with IL7R, NDRG1, TRPC1, CLDN10, TDO2, KPNA2, and MEG3, among others.
The invention also describes methods for assessing the likelihood that hepatocellular carcinoma will recur or lead to death. These methods may help determine whether adjuvant therapy should be administered to a patient.
Career Highlights
Cheung is associated with Versitech, Inc. and The University of Hong Kong. The patent’s focus on molecular probes and clinical assessment reflects an effort to connect biological information with decisions about liver cancer prognosis and treatment.
Collaborations
His listed coworkers include Sheung Tat Fan and Fung Yi Cheung. Their names are associated with the collaborative research context surrounding the liver cancer invention.
Conclusion
Siu Tim Cheung’s listed patent addresses the use of polynucleotide probes to support prognosis and treatment decisions for hepatocellular carcinoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile